ALX Oncology Holdings Inc.

07/31/2024 | Press release | Distributed by Public on 07/31/2024 03:51

ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN 06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2 Positive[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.